|
1
|
Fidelity Investments
Boston,
Massachusetts
|
$30.8M
|
-$1.49M
|
-83,296
|
-3%
|
|
|
2
|
MPM BioImpact
Boston,
Massachusetts
|
$10.4M
|
+$1.24M
|
+69,640
|
+10%
|
|
|
3
|
|
$8.87M
|
+$244K
|
+13,648
|
+2%
|
|
|
4
|
Siren LLC
Greenwich,
Connecticut
|
$7.42M
|
-$160K
|
-8,964
|
-2%
|
|
|
5
|
Vanguard Group
Malvern,
Pennsylvania
|
$6.64M
|
+$1.32M
|
+74,057
|
+17%
|
|
|
6
|
Erste Asset Management
Vienna,
Austria
|
$3.43M
|
+$1.54M
|
+86,445
|
+50%
|
|
|
7
|
Geode Capital Management
Boston,
Massachusetts
|
$2.97M
|
+$75.8K
|
+4,243
|
+2%
|
|
|
8
|
State Street
Boston,
Massachusetts
|
$2.65M
|
+$509K
|
+28,505
|
+17%
|
|
|
9
|
|
$2.57M
|
-$1.42M
|
-79,703
|
-29%
|
|
|
10
|
683 Capital Management
New York
|
$1.98M
|
+$447K
|
+25,000
|
+20%
|
|
|
11
|
Citadel Advisors
Miami,
Florida
|
$1.94M
|
-$3M
|
-167,703
|
-53%
|
|
|
12
|
Northern Trust
Chicago,
Illinois
|
$1.22M
|
-$48.1K
|
-2,693
|
-3%
|
|
|
13
|
Marshall Wace
London,
United Kingdom
|
$509K
|
+$690K
|
+38,605
|
New
|
|
|
14
|
UBS Group
Zurich,
Switzerland
|
$410K
|
+$242K
|
+13,538
|
+77%
|
|
|
15
|
Charles Schwab
San Francisco,
California
|
$386K
|
+$44.7K
|
+2,500
|
+9%
|
|
|
16
|
Nuveen
Charlotte,
North Carolina
|
$367K
|
-$790K
|
-44,230
|
-61%
|
|
|
17
|
Freestone Capital Holdings
Seattle,
Washington
|
$342K
|
–
|
–
|
–
|
|
|
18
|
Ikarian Capital
Dallas,
Texas
|
$292K
|
-$536K
|
-30,000
|
-58%
|
|
|
19
|
Delphi Financial Group
Wilmington,
Delaware
|
$290K
|
–
|
–
|
–
|
|
|
20
|
Bank of New York Mellon
New York
|
$276K
|
+$27.3K
|
+1,530
|
+8%
|
|
|
21
|
ALPS Advisors
Denver,
Colorado
|
$256K
|
-$20.7K
|
-1,158
|
-6%
|
|
|
22
|
|
$235K
|
-$115K
|
-6,412
|
-26%
|
|
|
23
|
GSA Capital Partners
London,
United Kingdom
|
$221K
|
+$300K
|
+16,791
|
New
|
|
|
24
|
|
$208K
|
-$210K
|
-11,750
|
-43%
|
|
|
25
|
Twin Focus Capital Partners
Boston,
Massachusetts
|
$198K
|
+$53.6K
|
+3,000
|
+25%
|
|
